Skip to content
Riskpilot
← Back to search
Sign in
Get full access
EPITOPEA APS NUF
NUF
Active
Org 935697018
Åsliveien 21, 1368
Stabekk
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2025 · <1 year old
— employees
www.epitopea.com
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
EPITOPEA APS NUF
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2025
EBITDA
NOK millions
0M
-1M
-2M
-3M
-4M
-3M
2025
Income statement
NOK thousands
Item
2025
Revenue
0
Staff expenses
−2 772
EBITDA
−3 499
Depreciation & amort.
−0
EBIT
−3 499
Net financials
3
Profit before tax
−3 495
Tax
−769
Net profit
−2 726
Balance sheet
NOK thousands
Item
2025
Total assets
1 318
Equity
−2 726
Long-term debt
0
Short-term debt
4 044
Total debt
4 044
Financial ratios
5-year trend
EBITDA margin
-349867500.0%
This company
15.8%
Market median
-2214351366% vs market
2025
2025
Equity ratio
-206.9%
This company
38.2%
Market median
-642% vs market
2025
2025
Return on equity
-272637400.0%
This company
18.4%
Market median
-1481725100% vs market
2025
2025
Net profit margin
-272637400.0%
This company
8.1%
Market median
-3365893927% vs market
2025
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2025
2025
Debt / equity
1.48×
This company
0.62×
Market median
-139% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-07-03 – 2025-12-31
View
PDF
More on EPITOPEA APS NUF
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
